ArticleJAMA network open2025
Automated EEG Background Analysis and 2-Year Outcomes in Neonatal Hypoxic-Ischemic Encephalopathy.
Article in JAMA network open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Neonatal Epilepsy: Beyond Seizures in a Developing Brain-A Narrative Review.Brain sciences · 2026Review
- Prolonged Antibiotic Exposure During Gestation Increases the Severity of Perinatal Asphyxia as Measured by EEG Reactivity in Rodents.Neurology international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Importance: Hypoxic-ischemic encephalopathy (HIE) remains an important contributor to neonatal mortality and morbidity despite therapeutic hypothermia. Accurate early prognostication of outcomes is essential for clinical management and risk stratification in future trials. Objective: To evaluate the feasibility and estimative ability of automated electroencephalographic (EEG) background analysis in projecting neurodevelopmental outcomes in neonates with HIE using the Brain State of the Newborn (BSN) score. Design, Setting, and Participants: This cohort study was a secondary analysis of the High-Dose Erythropoietin for Asphyxia and Encephalopathy (HEAL) trial, which enrolled infants born between January 25, 2017, and October 9, 2019, and were followed up at age 2 years (between age 22 and 36 months). Nine academic centers across the US provided raw EEG data starting within the first 24 hours of life. The data were analyzed between August 15, 2024, and August 25, 2025. Main Outcomes and Measures: The primary outcome was death or severe neurodevelopmental impairment (NDI) at age 2 years. The BSN scores were computed using a cloud service and correlated with expert reader interpretations. Generalized linear mixed models were used to assess the estimative capabilities (quantified via cross-validated area under the receiver operating characteristic curve [AUROC]) of clinical variables and BSN score for severe NDI or death. Results: Among 500 infants enrolled in the HEAL trial, 203 were included in the current analysis (median [IQR] gestational age, 39.3 [38.0-40.3] weeks; 121 male [59.6%]). Of these infants, 21 (10.3%) experienced severe NDI, and 28 (13.8%) died. The BSN scores correlated with expert reader EEG background classifications (Pearson correlation coefficient for median BSN, 0.69; 95% CI, 0.64-0.73). Adding median overall BSN score (AUROC, 0.90; 95% CI, 0.84-0.97) or median BSN score at all time points (AUROC, 0.93; 95% CI, 0.88-0.98) significantly improved the prognosis of severe NDI or death compared with clinical variables alone (AUROC, 0.79; 95% CI, 0.70-0.87). Prognostic accuracy of median BSN score overall was similar to expert assessments of EEG background (AUROC, 0.90; 95% CI, 0.81-0.98). Conclusions and Relevance: These findings suggest that automated EEG background analysis may provide an objective method for early prognostication in neonates with HIE. The BSN scores correlated with expert classifications and may aid in risk stratification. The BSN's role in the treatment of neonates with HIE in environments lacking expert EEG interpretation requires further study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.